SHARE

AVS Bio acquires IPA Europe

AVS Bio has acquired IPA Europe, a carve‑out of ImmunoPrecise Antibodies Ltd. based in the Netherlands. The deal expands AVS Bio’s capabilities in antibody discovery, protein expression, and biologics. Financial terms were not disclosed.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.